PhotoMedex Expected to Gain Market Share and 2 Stock Analyses to See Now

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Ryland Group Inc. (NYSE:RYL) has been removed from the short-term buy list at Deutsche Bank.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

PhotoMedex, Inc. (NASDAQ:PHMD) reported higher EPS but than expected by lower revenue, causing Maxim to think that a number of positive catalysts could boost the company’s revenues. The firm believes that the company will gain market share, and it keeps a Buy rating on the stock.

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) has reported a Q3 EPS of 8c, consensus 7c.

Don’t Miss: Are CBS Shares a Buy After Earnings?


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business